Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Abatacept may help some people with alopecia areata regrow hair.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

SESA oil is five times more effective and safe for hair and scalp issues than coconut oil.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Vitamin D Receptor is needed for hair growth in mice but not for skin stem cell maintenance.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Sweat gland stem cells help maintain glands, aid wound healing, and can regenerate skin structures.

The study found stem cells in minor salivary glands that can differentiate and are involved in tumor formation when exposed to tobacco.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Co5M offers a new way to observe and understand wound healing without labels.

Killing specific cells in hair follicles can lead to hair growth problems in mice.

Proteins influence the quality and traits of cashmere goat fleece, affecting hair strength and diameter.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Combining PRP with hydroquinone is more effective for treating melasma than using hydroquinone alone.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.